Genprex (GNPX) Announces Passing of CEO Rodney Varner

On May 8, 2024, Genprex (NASDAQ: GNPX) announced that Rodney Varner, the Company’s President and Chief Executive Officer and Chairman of the Company’s Board of Directors (the “Board”), passed away unexpectedly on May 7, 2024 due to complications from an ongoing illness.

Following Mr. Varner’s death, on May 8, 2024, the Board appointed Ryan Confer, Chief Financial Officer of Genprex since 2016, to serve as President and Chief Executive Officer of Genprex (in addition to his position as Chief Financial Officer of Genprex), effective immediately, consistent with the Company’s transition plan. On May 8, 2024, Mr. Confer was also appointed to the Board as a Class III director to fill the vacancy caused by Mr. Varner’s passing, to serve the remainder of such term expiring at the Company’s 2026 annual meeting of stockholders and until his successor has been duly elected and qualified.

You May Also Be Interested In

• Dave & Buster's names CFO Darin Harper as new CEO
• steute Technologies acquires Electro-Sensors in North America expansion
• LendingTree launches ChatGPT plug-in for mortgage rate browsing